Dealing with haemophilia

Case Study: Novo Nordisk Haemophilia Foundation

Novo Nordisk Haemophilia Foundation (NNHF) – Logo
Nordisk-real-header

Client: Novo Nordisk Haemophilia Foundation
Date: November 2021
Photographer: Mutunga Al-Amin
Location: Nairobi, Kenya

Fairpicture photographer Mutunga Al-Amin visited the Kenyatta National Hospital in Nairobi and Muranga District Hospital in Muranga, Kenya, on behalf of the Novo Nordisk Haemophilia Foundation. There, he met 29-year-old Moses Muthii Muriuki and his 11-year-old brother, Reuben Ngori Muriuki, among others. Both were diagnosed with haemophilia type A.

Haemophilia is a mostly inherited bleeding disorder that affects the blood’s ability to clot properly. If the person doesn’t receive adequate care and treatment, bleedings into muscles and joints can lead to extreme pain, damages of the affected joints and in some cases to death.

The Novo Nordisk Haemophilia Foundation and Novo Nordisk Foundation are supporting a project aiming to accelerate access to blood disorders care in both Kenya and Tanzania, by establishing 16 centres to provide basic care, diagnosis and treatment of blood disorders in both countries.

Client

Novo Nordisk Haemophilia Foundation

Visual Creator

Mutunga Al-Amin

Theme

Dealing with haemophilia

Locations

Nairobi, Kenya

Date

November 2021

kenya

When haemophilia is treated quickly and adequately, damage and pain can be reduced and affected people can live without severe impairments.

21101_NovoNordiskHealthcareKenya_Fairpicture_014

Client: Novo Nordisk Haemophilia Foundation
Date: November 2021
Photographer: Mutunga Al-Amin
Location: Nairobi, Kenya

The preliminary examination

Jane Mugacha, 58, is a healthcare provider at Muranga District Hospital. She examines Moses Muthii Muriuki’s right foot, to ensure that his ankle is fine.

21101_NovoNordiskHealthcareKenya_Fairpicture_015

Client: Novo Nordisk Haemophilia Foundation
Date: November 2021
Photographer: Mutunga Al-Amin
Location: Nairobi, Kenya

The factor treatment

Moses Muthii Muriuki is about to receive his factor treatment (an essential blood-clotting protein).

quote icon

The project teams will build strategic alliances, empowering the patient organisations to raise awareness and advocate for improved care to finally anchor blood disorders care within the national healthcare systems.

Milena Marra
Novo Nordisk Haemophilia Foundation

21101_NovoNordiskHealthcareKenya_Fairpicture_012


Client: Novo Nordisk Haemophilia Foundation
Date: November 2021
Photographer: Mutunga Al-Amin
Location: Nairobi, Kenya

The debrief

After his treatment, Moses Muthii Muriuki is hopeful that he will get better in a few days. The health care provider records the information that will be used the next time he will visit the clinic.

Start your photo or video project

Sign up

Sign up to the platform to get started, contact us or schedule a free call with our team.

Contact us

Case studies

my-climate_header
CASE STUDY

November 2023 - Foundation myclimate

Climate Protection in Photos

myclimate and Fairpicture joint forces to capture authentic impact stories of their climate protection projects.

Learn more about Climate Protection in Photos

header
CASE STUDY

August 2023 - CARE Germany

Collaboration on an international exhibition

Care Germany worked with visual creators to portray midwives in Côte d'Ivoire, Uganda, Cambodia and Ukraine.

Learn more about Collaboration on an international exhibition

digger_header_1330x690
CASE STUDY

May 2022 - Digger Foundation

Humanitarian Mine Clearance

About the socio-economic impact of a demining process on the local population Battambang, Cambodia.

Learn more about Humanitarian Mine Clearance

Stay up to date

Get our monthly newsletter

Fairpicture is moving fast. Make sure you don't miss out on the latest news. Join our email newsletter and connect with us on LinkedIn and Instagram.

After signing up for the newsletter, you will also receive occasional emails about events and offers from Fairpicture. You may opt out any time. Here’s our privacy policy.